On the recordApril 4, 2022
Five years ago, when Congress last addressed user fee reauthorization, I asked Dr. Woodcock of the FDA a question on the availability of biosimilar drugs.
Source
congress.govFive years ago, when Congress last addressed user fee reauthorization, I asked Dr. Woodcock of the FDA a question on the availability of biosimilar drugs.
Kaine reflects on past discussions regarding biosimilar drug availability.
Share
More from Tim Kaine
I think the right answer here is voter ID laws passed at the state level.
His threat to waste even more of our dwindling weapons on Oman — a country the United States has a strong diplomatic relationship and a free trade agreement with — makes real adversaries like China and Russia rub their hands with glee.
The violence committed by Israeli settlers in the West Bank is reaching an unprecedented level, and as a result more and more Americans and Palestinians are being killed and injured. These actions – and the Israeli government’s lack of…